ADIPOQ and endometrial cancer: Three more recent meta-analyses have reported that adiponectin levels and leptin/adiponectin ratio are considered as predictive and prognostic biomarkers in order to guarantee early diagnosis and disease monitoring of endometrial cancer, especially in postmenopausal women [118,119,120,121].